Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makoto Inada

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Cureus|December 29, 2022
The Epidemiology of Healthcare-Associated Bloodstream Infection in an Adult Intensive Care Unit: A Retrospective Cohort Study in a Single Tertiary Care Hospital in Hanoi, VietnamMakoto Inada, Masahiro Ishikane, Nguyen Gia Binh, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 8, 2021
Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC<sub>50</sub>) of neutralizing antibodiesMakoto Inada, Masahiro Ishikane, Mari Terada, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 25, 2021
No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severityHidetoshi Nomoto, Satoshi Kutsuna, Kazu Okuma, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 23, 2023
Treatment with tecovirimat of the first two cases of monkeypox in JapanMakoto Inada, Sho Saito, Shinya Tsuzuki, et al.
Japanese Journal of Infectious Diseases|April 2, 2023
Genetic Characteristics of the Virus Detected in the First Mpox Imported Case in Tokyo, JapanFumi Kasuya, Akane Negishi, Ryota Kumagai, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 7, 2021
Clinical course of alopecia after COVID-19Tetsuya Suzuki, Satoshi Kutsuna, Sho Saito, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 15, 2024
Comparison of the effects of cefmetazole and meropenem on microbiome: A pilot studyKayoko Hayakawa, Sho Saito, Tohru Miyoshi-Akiyama, et al.
Journal of Atherosclerosis and Thrombosis|February 14, 2024
Unfractionated Heparin Safety in COVID-19: Incidence and Risks of Bleeding Complications in JapanLubna Sato, Noriko Iwamoto, Yuko Kakumoto, et al.
European Journal of Clinical Investigation|May 4, 2022
Interferon lambda 3 in the early phase of coronavirus disease-19 can predict oxygen requirementTetsuya Suzuki, Noriko Iwamoto, Shinya Tsuzuki, et al.
Heliyon|October 16, 2023
Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolvedTetsuya Suzuki, Yusuke Asai, Kozue Takahashi, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Cureus|December 29, 2022
The Epidemiology of Healthcare-Associated Bloodstream Infection in an Adult Intensive Care Unit: A Retrospective Cohort Study in a Single Tertiary Care Hospital in Hanoi, VietnamMakoto Inada, Masahiro Ishikane, Nguyen Gia Binh, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 8, 2021
Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC<sub>50</sub>) of neutralizing antibodiesMakoto Inada, Masahiro Ishikane, Mari Terada, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 25, 2021
No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severityHidetoshi Nomoto, Satoshi Kutsuna, Kazu Okuma, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 23, 2023
Treatment with tecovirimat of the first two cases of monkeypox in JapanMakoto Inada, Sho Saito, Shinya Tsuzuki, et al.
Japanese Journal of Infectious Diseases|April 2, 2023
Genetic Characteristics of the Virus Detected in the First Mpox Imported Case in Tokyo, JapanFumi Kasuya, Akane Negishi, Ryota Kumagai, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 7, 2021
Clinical course of alopecia after COVID-19Tetsuya Suzuki, Satoshi Kutsuna, Sho Saito, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 15, 2024
Comparison of the effects of cefmetazole and meropenem on microbiome: A pilot studyKayoko Hayakawa, Sho Saito, Tohru Miyoshi-Akiyama, et al.
Journal of Atherosclerosis and Thrombosis|February 14, 2024
Unfractionated Heparin Safety in COVID-19: Incidence and Risks of Bleeding Complications in JapanLubna Sato, Noriko Iwamoto, Yuko Kakumoto, et al.
European Journal of Clinical Investigation|May 4, 2022
Interferon lambda 3 in the early phase of coronavirus disease-19 can predict oxygen requirementTetsuya Suzuki, Noriko Iwamoto, Shinya Tsuzuki, et al.
Heliyon|October 16, 2023
Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolvedTetsuya Suzuki, Yusuke Asai, Kozue Takahashi, et al.
Pageof 4